{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:40:39Z","timestamp":1785174039834,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and aim<\/jats:title>\n            <jats:p>Hypomagnesemia and clotting disorders have been reported among people with diabetes especially those with type 2 diabetes (T2DM). Magnesium plays a crucial role in hemostasis and hypomagnesemia was found to increase the thrombotic risk. The patho-mechanism linking magnesium, clotting disorders, and diabetic microangiopathy in T1DM remains to be unraveled. Hence this study aimed to assess the magnesium level among children and adolescents with T1DM compared to healthy controls and to correlate it with coagulopathy markers and diabetic microangiopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Forty-six children and adolescents with T1DM &amp; 46 controls were assessed for serum magnesium, prothrombin time (PT), activated-partial thromboplastin time (aPTT), plasminogen activator inhibitor-1 (PAI-1) and HbA1c. The Toronto clinical scoring system, fundus, urinary microalbumin, and serum fasting lipids were used to assess diabetic microangiopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Children and adolescents with T1DM have significantly lower magnesium, PT, aPTT, and significantly higher PAI-1 than controls (<jats:italic>p<\/jats:italic>&lt;0.001), this is more evident in those having microangiopathy than those without (<jats:italic>p<\/jats:italic>&lt;0.001). Serum magnesium is positively correlated with PT, aPTT, and HDL and negatively correlated with insulin daily dose, PAI-1, HbA1c, triglycerides, and urinary microalbumin. Multivariate-logistic regression revealed that diabetes duration, HbA1c, PT, aPTT, PAI-1, and urinary microalbumin were independently associated with serum magnesium among children and adolescents with T1DM (p&lt;0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Children and adolescents with T1DM have lower magnesium levels than controls; that is more pronounced among those having microangiopathy. Low serum magnesium is associated with poor glycemic control, coagulopathy, and diabetic microangiopathy among children and adolescents with T1DM. Magnesium supplementation combined with standard insulin therapy in pediatric patients with T1DM is recommended for better glycemic control and prevention of diabetic microangiopathy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41387-025-00368-9","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T16:44:31Z","timestamp":1743525871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Magnesium, fibrinolysis and clotting interplay among children and adolescents with type 1 diabetes mellitus; potential mediators of diabetic microangiopathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Dalia N.","family":"Toaima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kholoud S.","family":"Abdel-Maksoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Atef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-8835","authenticated-orcid":false,"given":"Nouran Y.","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"368_CR1","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.2337\/DC13-1776","volume":"37","author":"A Agren","year":"2014","unstructured":"Agren A, J\u00f6rneskog G, Elgue G, Henriksson P, Wallen H, Wiman B. Increased incorporation of antiplasmin into the fibrin network in patients with type 1 diabetes. Diab Care. 2014;37:2007\u201314. https:\/\/doi.org\/10.2337\/DC13-1776.","journal-title":"Diab Care"},{"key":"368_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-0039-3402808","volume":"120","author":"A Sobczak","year":"2020","unstructured":"Sobczak A, Phoenix F, Pitt S, Ajjan R, Stewart A. Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis. Thromb Haemost. 2020;120:243\u201352. https:\/\/doi.org\/10.1055\/s-0039-3402808.","journal-title":"Thromb Haemost"},{"key":"368_CR3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcp\/aqw066","volume":"145","author":"S Mannu\u00df","year":"2016","unstructured":"Mannu\u00df S, Schuff-Werner P, Drei\u00dfiger K, Kohlschein P. Magnesium sulfate as an alternative in vitro anticoagulant for the measurement of platelet parameters? Am J Clin Pathol. 2016;145:806\u201314.","journal-title":"Am J Clin Pathol"},{"key":"368_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10534-021-00328-7","volume":"34","author":"A Mathew","year":"2021","unstructured":"Mathew A, Panonnummal R. Magnesium\u2019-the master cation-as a drug\u2014possibilities and evidences. Biometals. 2021;34:955\u201386. https:\/\/doi.org\/10.1007\/s10534-021-00328-7.","journal-title":"Biometals"},{"key":"368_CR5","doi-asserted-by":"publisher","unstructured":"Van Dijk P, Waanders F, Qiu J, de Boer H, van Goor H, Bilo H. Hypomagnesemia in persons with type 1 diabetes: associations with clinical parameters and oxidative stress. Therapeutic Advances in Endocrinology and Metabolism. 2020;11. https:\/\/doi.org\/10.1177\/2042018820980240.","DOI":"10.1177\/2042018820980240"},{"key":"368_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/db15-1028","volume":"65","author":"L Gommers","year":"2016","unstructured":"Gommers L, Hoenderop J, Bindels R, de Baaij J. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016;65:3\u201313. https:\/\/doi.org\/10.2337\/db15-1028.","journal-title":"Diabetes"},{"key":"368_CR7","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1007\/s12011-023-03591-6","volume":"201","author":"Q Ren","year":"2023","unstructured":"Ren Q, Wang H, Zeng Y, Tan X, Cheng X, Zhou T, et al. The Association Between Serum Magnesium Levels and Gestational Diabetes Mellitus: a Systematic Review and Meta-Analysis. Biol Trace Elem Res. 2023;201:5115\u201325. https:\/\/doi.org\/10.1007\/s12011-023-03591-6.","journal-title":"Biol Trace Elem Res"},{"key":"368_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03915-3","volume":"11","author":"S Ebrahimi Mousavi","year":"2021","unstructured":"Ebrahimi Mousavi S, Ghoreishy SM, Hemmati A, Mohammadi H. Association between magnesium concentrations and prediabetes: a systematic review and meta-analysis. Sci Rep. 2021;11:24388. https:\/\/doi.org\/10.1038\/s41598-021-03915-3.","journal-title":"Sci Rep"},{"key":"368_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.dsx.2020.01.015","volume":"14","author":"A Rodrigues","year":"2020","unstructured":"Rodrigues A, Melo A, Domingueti C. Association between reduced serum levels of magnesium and the presence of poor glycemic control and complications in type 1 diabetes mellitus: A systematic review and meta-analysis. Diab Metab Syndrome: Clin Res Rev. 2020;14:127\u201334. https:\/\/doi.org\/10.1016\/j.dsx.2020.01.015.","journal-title":"Diab Metab Syndrome: Clin Res Rev"},{"key":"368_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s12276-020-0397-x","volume":"52","author":"H Lin","year":"2020","unstructured":"Lin H, Xu L, Yu S, Hong W, Huang M, Xu P. Therapeutics targeting the fibrinolytic system. Exp Mol Med. 2020;52:367\u201379. https:\/\/doi.org\/10.1038\/s12276-020-0397-x.","journal-title":"Exp Mol Med"},{"key":"368_CR11","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.3390\/ijms22052721","volume":"22","author":"M Sillen","year":"2021","unstructured":"Sillen M, Declerck PJ. A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? Int J Mol Sci. 2021;22:2721. https:\/\/doi.org\/10.3390\/ijms22052721.","journal-title":"Int J Mol Sci"},{"key":"368_CR12","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1161\/01.ATV.0000242905.41404.68","volume":"26","author":"M Alessi","year":"2006","unstructured":"Alessi M, Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol. 2006;26:2200\u20137. https:\/\/doi.org\/10.1161\/01.ATV.0000242905.41404.68.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"368_CR13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/pedi.13454","volume":"23","author":"I Libman","year":"2022","unstructured":"Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, Tung JY, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diab. 2022;23:1160\u201374. https:\/\/doi.org\/10.1111\/pedi.13454.","journal-title":"Pediatr Diab"},{"key":"368_CR14","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/nu11081752","volume":"11","author":"S Couch","year":"2019","unstructured":"Couch S, Urbina E, Crandell J, Liese A, Dabelea D, Kim G, et al. Body Mass Index Z-Score Modifies the Association between Added Sugar Intake and Arterial Stiffness in Youth with Type 1 Diabetes: The Search Nutrition Ancillary Study. Nutrients 2019;11:1752.","journal-title":"Nutrients"},{"key":"368_CR15","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/nu12072062","volume":"12","author":"S Orlova","year":"2020","unstructured":"Orlova S, Dikke G, Pickering G, Konchits S, Starostin K, Bevz A. Magnesium Deficiency Questionnaire: A New Non-Invasive Magnesium Deficiency Screening Tool Developed Using Real-World Data from Four Observational Studies. Nutrients. 2020;12:2062. https:\/\/doi.org\/10.3390\/nu12072062.","journal-title":"Nutrients"},{"key":"368_CR16","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/s0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL 3rd, Klein RE, Lee P, Agardh C, Davis M, et al. Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677\u201382. https:\/\/doi.org\/10.1016\/s0161-6420(03)00475-5.","journal-title":"Ophthalmology"},{"key":"368_CR17","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","volume":"25","author":"V Bril","year":"2002","unstructured":"Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diab Care. 2002;25:2048\u201352.","journal-title":"Diab Care"},{"key":"368_CR18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"368_CR19","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","volume":"1","author":"GC Viberti","year":"1982","unstructured":"Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;1:1430\u20132.","journal-title":"Lancet"},{"key":"368_CR20","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.2337\/dc14-2898","volume":"38","author":"I Hirsch","year":"2015","unstructured":"Hirsch I. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does. Diab Care. 2015;38:1610\u20134. https:\/\/doi.org\/10.2337\/dc14-2898.","journal-title":"Diab Care"},{"key":"368_CR21","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00125-011-2301-7","volume":"55","author":"K Hess","year":"2012","unstructured":"Hess K, Alzahrani S, Mathai M, Schroeder V, Carter A, Howell G, et al. A novel mechanism for hypofibrinolysis in diabetes: The role of complement C3. Diabetologia. 2012;55:1103\u201313. https:\/\/doi.org\/10.1007\/s00125-011-2301-7.","journal-title":"Diabetologia"},{"key":"368_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-017-0515-9","volume":"16","author":"K Kearney","year":"2017","unstructured":"Kearney K, Tomlinson D, Smith K, Ajjan R. Hypofibrinolysis in diabetes: A therapeutic target for the reduction of cardiovascular risk. Cardiovasc Diabetol 2017;16:1\u201317. https:\/\/doi.org\/10.1186\/s12933-017-0515-9.","journal-title":"Cardiovasc Diabetol"},{"key":"368_CR23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MBC.0b013e328338dbe8","volume":"21","author":"G Lippi","year":"2010","unstructured":"Lippi G, Salvagno GL, Ippolito L, Franchini M, Favaloro EJ. Shortened activated partial thromboplastin time: causes and management. Blood Coagul Fibrinolysis. 2010;21:459\u201363.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"368_CR24","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1210\/jcem.85.9.6779","volume":"85","author":"R Barazzoni","year":"2000","unstructured":"Barazzoni R, Zanetti M, Davanzo G, Kiwanuka E, Carraro P, Tiengo A, et al. Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. J Clin Endocrinol Metab. 2000;85:3121\u20135. https:\/\/doi.org\/10.1210\/jcem.85.9.6779.","journal-title":"J Clin Endocrinol Metab"},{"key":"368_CR25","doi-asserted-by":"publisher","first-page":"e16470","DOI":"10.1371\/journal.pone.0016470","volume":"6","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Zhang J, Zhang J, Wu J. Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values. PLOS ONE. 2011;6:e16470. https:\/\/doi.org\/10.1371\/journal.pone.0016470.","journal-title":"PLOS ONE"},{"key":"368_CR26","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-6-485","volume":"6","author":"B Sapkota","year":"2013","unstructured":"Sapkota B, Shrestha SK, Poudel S. Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus. BMC Res Notes. 2013;6:485.","journal-title":"BMC Res Notes"},{"key":"368_CR27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdiacomp.2014.01.006","volume":"28","author":"H Kim","year":"2014","unstructured":"Kim H, Kim J, Park S, Kim Y, Nam-Goong I, Kim E. High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications. J Diab Complicat. 2014;28:365\u20139.","journal-title":"J Diab Complicat"},{"key":"368_CR28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s12288-017-0793-0","volume":"33","author":"C Binay","year":"2017","unstructured":"Binay C, Bozkurt Turhan A, Simsek E, Bor O, Akay OM. Evaluation of coagulation profile in children with type1 diabetes mellitus using rotational thromboelastometry. Indian J Hematol Blood Transfus. 2017;33:574\u201380.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"368_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1055\/s-0039-1701011","volume":"120","author":"W Sumaya","year":"2020","unstructured":"Sumaya W, Wallentin L, James S, Siegbahn A, Gabrysch K, Himmelmann A, et al. Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study. Thromb Haemost 2020;120:412\u201322. https:\/\/doi.org\/10.1055\/s-0039-1701011.","journal-title":"Thromb Haemost"},{"key":"368_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jdiacomp.2014.01.011","volume":"28","author":"A Adly","year":"2014","unstructured":"Adly A, Elbarbary N, Ismail E, Hassan S. Plasminogen activator inhibitor-1 (PAI-1) in children and adolescents with type 1 diabetes mellitus: relation to diabetic micro-vascular complications and carotid intima media thickness. J Diab Complicat. 2014;28:340\u20137. https:\/\/doi.org\/10.1016\/j.jdiacomp.2014.01.011.","journal-title":"J Diab Complicat"},{"key":"368_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.6065\/apem.2040142.071","volume":"26","author":"M Aleman","year":"2021","unstructured":"Aleman M, D\u00edaz E, Luciardi M, Mariani A, Baz\u00e1n M, Abregu A. Hemostatic state of children with type 1 diabetes. Ann Pediatr Endocrinol Metab. 2021;26:99\u2013104. https:\/\/doi.org\/10.6065\/apem.2040142.071.","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"368_CR32","doi-asserted-by":"publisher","first-page":"8225","DOI":"10.1074\/jbc.273.14.8225","volume":"273","author":"Y Chen","year":"1998","unstructured":"Chen Y, Su M, Walia R, Hao Q, Covington J, Vaughan D. Sp1 Sites Mediate Activation of the Plasminogen Activator Inhibitor-1 Promoter by Glucose in Vascular Smooth Muscle Cells. J Biol Chem 1998;273:8225\u201331. https:\/\/doi.org\/10.1074\/jbc.273.14.8225.","journal-title":"J Biol Chem"},{"key":"368_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1210\/endrev\/bnac028","volume":"44","author":"L Oost","year":"2023","unstructured":"Oost L, Tack C, de Baaij J. Hypomagnesemia and Cardiovascular Risk in Type 2 Diabetes. Endocr Rev. 2023;44:357\u201378. https:\/\/doi.org\/10.1210\/endrev\/bnac028.","journal-title":"Endocr Rev"},{"key":"368_CR34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/EJE-16-0517","volume":"176","author":"S Kurstjens","year":"2017","unstructured":"Kurstjens S, de Baaij JHF, Bouras H, Bindels RJM, Tack CJJ, Hoenderop JGJ. Determinants of hypomagnesemia in patients with type 2 diabetes mellitus. Eur J Endocrinol. 2017;176:19.","journal-title":"Eur J Endocrinol"},{"key":"368_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10436-0","volume":"12","author":"L Oost","year":"2022","unstructured":"Oost L, van Heck J, Tack C, de Baaij J. The association between hypomagnesemia and poor glycaemic control in type 1 diabetes is limited to insulin resistant individuals. Sci Rep 2022;12:6433. https:\/\/doi.org\/10.1038\/s41598-022-10436-0.","journal-title":"Sci Rep"},{"key":"368_CR36","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.3390\/nu15102355","volume":"15","author":"R Fritzen","year":"2023","unstructured":"Fritzen R, Davies A, Veenhuizen M, Campbell M, Pitt SJ, Ajjan RA, et al. Magnesium Deficiency and Cardiometabolic Disease. Nutrients 2023;15:2355. https:\/\/doi.org\/10.3390\/nu15102355","journal-title":"Nutrients"},{"key":"368_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/1753-0407.12118","volume":"6","author":"A Galli-Tsinopoulou","year":"2014","unstructured":"Galli-Tsinopoulou A, Maggana I, Kyrgios I, Mouzaki K, Grammatikopoulou MG, Stylianou C, et al. Association between magnesium concentration and HbA1c in children and adolescents with type 1 diabetes mellitus. J Diab. 2014;6:369\u201377. https:\/\/doi.org\/10.1111\/1753-0407.12118.","journal-title":"J Diab"},{"key":"368_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0946-672X(97)80044-2","volume":"11","author":"A Allegra","year":"1997","unstructured":"Allegra A, Corsonello A, Buemi M, D\u2019Angelo R, di Benedetto A, Bonanzinga S, et al. Plasma, erythrocyte and platelet magnesium levels in type 1 diabetic patients with microalbuminuria and clinical proteinuria. J Trace Elem Med Biol. 1997;11:154\u20137. https:\/\/doi.org\/10.1016\/S0946-672X(97)80044-2.","journal-title":"J Trace Elem Med Biol"},{"key":"368_CR39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF00400735","volume":"38","author":"I Arslano\u011flu","year":"1995","unstructured":"Arslano\u011flu I. Hypomagnesaemia in childhood IDDM and risk of nephropathy. Diabetologia. 1995;38:629.","journal-title":"Diabetologia"},{"key":"368_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2337\/diab.41.1.35","volume":"41","author":"G Grafton","year":"1992","unstructured":"Grafton G, Bunce C, Sheppard M, Brown G, Baxter M. Effect of Mg2+ on Na+-Dependent Inositol Transport: Role for Mg2+ in Etiology of Diabetic Complications. Diabetes. 1992;41:35\u201339. https:\/\/doi.org\/10.2337\/diab.41.1.35.","journal-title":"Diabetes"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00368-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00368-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T16:45:18Z","timestamp":1743525918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00368-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1038\/s41387-025-00368-9","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Ethical Committee of Ain Shams University with an approval number MS 185\/2022 and written informed consent was obtained from all cases and their legal guardians before participation. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"13"}}